Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition in Patients With Change From Botulinum Toxin Type A

NCT02175719 · clinicaltrials.gov ↗
COMPLETED
Status
150
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Eisai Co., Ltd.